The 9 new Scientific Board of Advisors aren’t scientist
The 9 new Scientific Board of Advisors aren’t scientist that lend to Leronlimabs and cytodyn credibility?
I’m sorry, but for being a virologist or whatever it is you are, that was a pretty stupid comment saying cytodyn does not have scientist backing the company.
Maybe you are a deep thinker? Nah, here I’ll help you out then.
I’m assuming you could agree Dr. Geto Hutter lends to cytodyn credibility. If not you might want to read his bio again. Stop with your short sided comments and your BS copy and past scientific post.
One thing I do for a living is sniff out bull shit. I can smell it from a mile away. That’s why you lost all credibility with me.
(Dr. Gero Hütter is a German hematologist who developed and performed the first allogeneic transplantation with natural CCR5 depleted stem cells in a leukemia patient with HIV-infection in 2004, during his residency in hematology, oncology and transfusion medicine at Charité Hospital in Berlin, Germany. Since then, the patient who is now known as “the Berlin patient,” has not resumed antiretroviral therapy, nor has he had a relapse of HIV disease.
In 2009, Dr Hütter became the head of the stem cell unit of the Institute of Transfusion Medicine and Immunology Mannheim of the Heidelberg University. There, he directs the research group of personalized stem therapy, which is supported by a grant from the Bill & Melinda Gates foundation.) @ MD VIROLOGIST
12
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
iAnthus Capital Holdings Inc. Announces Q2 2025 Results iAnthus Capital Holdings, Inc. is a prominent player in the cannabis industry, operating across various states in the U.S. They have recently shared their financial results for the second quarter of 2025. This report outlines the company’s financial health, revealing key insights into revenue and earnings amid...
Continue Reading
Tesla's Stock Sees Pullback Following Robotaxi Reveal Tesla, Inc. (NASDAQ: TSLA) found itself in a precarious position in pre-market trading as shares dipped sharply. This downturn came in the wake of a much-anticipated event showcasing the company's Robotaxi, dubbed “We, Robot.” Despite the excitement surrounding the autonomous vehicle, the unveil did not produce the...
Continue Reading
Mexico Stock Market Overview The stock market in Mexico is experiencing notable gains, signaling a healthy economic environment and investor confidence. On the most recent trading day, the market sentiment was buoyed by strong performance across various sectors. S&P/BMV IPC Performance The S&P/BMV IPC ended up 0.46%, marking a positive closing for investors. Key sectors...
Continue Reading
Project Kesher's Empowerment Focus at Davos Project Kesher, a distinguished nonprofit organization dedicated to advocating for women's rights, is making significant strides at the World Economic Forum Annual Meeting in Switzerland. Since its establishment in 1989, the organization has worked tirelessly to elevate the status of women, foster civil society, and revitalize...
Continue Reading
Centene Corporation's Legal Troubles Centene Corporation (NYSE: CNC), a prominent player in the healthcare sector, is currently facing serious legal issues. A recent lawsuit filed against the company and some of its senior executives has raised concerns about potential violations of federal securities laws. What Prompted the Lawsuit? The lawsuit, initiated by the...
Continue Reading
